Adverum Biotechnologies to Present at the Jefferies Global Healthcare Conference
Event: | Jefferies Global Healthcare Conference |
Date: | June 7, 2017 |
Time: | 1:30 – 2:00 p.m. ET |
Location: | New York, NY |
A live and replay video webcast of the presentation will be available from Adverum’s website at http://investors.adverum.com.
About
Adverum is a gene therapy company advancing novel medicines that can offer life-changing benefits to patients living with serious rare and ocular diseases. Adverum has a robust pipeline that includes product candidates designed to treat wet age-related macular degeneration (wAMD) and rare diseases alpha-1 antitrypsin (A1AT) deficiency and hereditary angioedema (HAE). Leveraging a next-generation adeno-associated virus (AAV)-based directed evolution platform, the Company generates product candidates designed to provide durable efficacy by inducing sustained expression of a therapeutic protein. Adverum has collaboration agreements with
Contacts for Adverum:Leone Patterson Chief Financial OfficerAdverum Biotechnologies, Inc. 650-665-7222 lpatterson@adverum.com Tricia Truehart Vice PresidentThe Trout Group LLC 646-378-2953 ttruehart@troutgroup.com